What is ExoAtlet?
ExoAtlet is at the forefront of developing sophisticated wearable exoskeletons, specifically engineered for individuals facing mobility challenges due to spinal cord injuries, multiple sclerosis, cerebral palsy, traumatic brain injury, and post-arthroplasty recovery. Their product line, including the advanced ExoAtlet II and the ExoRehabilitation system, integrates cutting-edge exoskeleton technology with established rehabilitation methodologies. This synergy aims to significantly enhance gait restoration and bolster patients' psychological well-being, ultimately empowering them to regain independence and improve their overall quality of life. ExoAtlet's solutions are deployed globally, serving clinics and healthcare providers to help countless patients achieve their aspirations of walking again.
How much funding has ExoAtlet raised?
ExoAtlet has raised a total of $2M across 1 funding round:
Unspecified
$2M
Unspecified (2017): $2M, investors not publicly disclosed
What's next for ExoAtlet?
The substantial enterprise-level funding ExoAtlet has garnered signals a pivotal phase for the company, likely focused on scaling production, expanding research and development into next-generation assistive technologies, and broadening its global market reach. This strategic capital infusion is expected to accelerate the adoption of their innovative exoskeleton solutions within clinical settings and potentially explore new applications in industrial or assistive robotics. The company's trajectory suggests a strong commitment to advancing patient care through technological innovation, positioning it as a key player in the burgeoning field of assistive robotics and rehabilitation.
See full ExoAtlet company page
